Glenmede Trust’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-88
Closed 2463
2020
Q3
$0 Hold
88
﹤0.01% 2637
2020
Q2
$0 Buy
+88
New +$759 ﹤0.01% 2684
2019
Q4
Sell
-24,329
Closed -$148K 3166
2019
Q3
$148K Hold
24,329
﹤0.01% 1273
2019
Q2
$101K Hold
24,329
﹤0.01% 1399
2019
Q1
$153K Buy
+24,329
New +$170K ﹤0.01% 1269
2017
Q4
Sell
-283
Closed -$1K 2846
2017
Q3
$1K Hold
283
﹤0.01% 2676
2017
Q2
$2K Hold
283
﹤0.01% 2526
2017
Q1
$2K Sell
283
-1,378,330
-100% -$14.4M ﹤0.01% 2526
2016
Q4
$14.9M Buy
1,378,613
+82,601
+6% +$1.1M 0.08% 326
2016
Q3
$21.2M Sell
1,296,012
-199,358
-13% -$2.81M 0.12% 275
2016
Q2
$14.3M Buy
1,495,370
+99,713
+7% +$1.09M 0.09% 316
2016
Q1
$19.6M Buy
+1,395,657
New +$14.4M 0.13% 263

Other funds holding NPTN

Glenmede Trust's NPTN Position: Q4 2020 in Review

Glenmede Trust sold out of NEOPHOTONICS CORP (NPTN) in Q4 2020, closing a stake of 88 shares.

Glenmede Trust first reported a position in NPTN in Q1 2016 and held it in 12 quarters. The position peaked at $21.2M in Q3 2016. 138 funds tracked by Wall St. Rank hold NPTN as of Q4 2020.

  • Glenmede Trust reported no remaining NEOPHOTONICS CORP position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 88 NEOPHOTONICS CORP shares in Q4 2020.
  • Glenmede Trust first reported a position in NEOPHOTONICS CORP in Q1 2016 and held it in 12 quarters.
  • Glenmede Trust's NEOPHOTONICS CORP position peaked at $21.2M in Q3 2016.
  • 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.